Kumiko Shimozawa

Suggest Changes
Learn More
We previously reported that survivin-2B, a splicing variant of survivin, was expressed in various types of tumors and that survivin-2B peptide might serve as a potent immunogenic cancer vaccine. The(More)
  • 1